Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction—Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial-Reference-Cited by-同舟云学术

Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction—Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial

Published:2018-05 Issue: Volume:199 Page:97-104
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Ambrosy Andrew P.,Bhatt Ankeet S.,Stebbins Amanda L.,Wruck Lisa M.,Fudim Marat,Greene Stephen J.,Kraus William E.,O'Connor Christopher M.,Piña Ileana L.,Whellan David J.,Mentz Robert J.

Funder

GE Healthcare

Amgen

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. The use of digoxin in patients with worsening chronic heart failure: reconsidering an old drug to reduce hospital admissions;Ambrosy;J Am Coll Cardiol,2014

2. Targeting digoxin dosing to serum concentration: is the bullseye too small?;Ambrosy;Eur J Heart Fail,2016

3. Digoxin for Worsening Chronic Heart Failure: Underutilized and Underrated;Ambrosy;JACC Heart Fail,2016

4. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE);Adams;Am Heart J,2005

5. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure;Gheorghiade;JAMA,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety profile of intravenous digoxin in Chinese patients with acute heart failure with reduced ejection fraction: a small-scale prospective cohort study;Frontiers in Pharmacology;2023-11-13

2. Whither digitalis? What we can still learn from cardiotonic steroids about heart failure and hypertension;American Journal of Physiology-Heart and Circulatory Physiology;2022-12-01

3. Characteristics and Outcomes of Suspected Digoxin Toxicity and Immune Fab Treatment Over the Past Two Decades—2000-2020;The American Journal of Cardiology;2022-11

4. The impact of Procyanidin extracted from Crataegus azarolus on rats with induced heart failure;Cellular and Molecular Biology;2022-09-30

5. Effects of Digoxin in Heart Failure (HF) With Reduced Ejection Fraction (EF);Cureus;2022-03-02